0001493152-24-032940 Sample Contracts

Amendment

Securities Purchase Agreement • August 19th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Securities Purchase Agreement
• Filed
  August 19th, 2024
• Company
  TNF Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Amendment (this “Amendment”), dated as of August [ ], 2024, is by and among TNF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).